Better Therapeutics Accounts Payable

Better Therapeutics (BTTX) currently reports a accounts payable of $2.3M as of September 2023. That compares with $1.3M in the prior-year period — up 83.9% year over year. Use the charts on this page to explore Better Therapeutics's accounts payable history and peer comparisons.

Better Therapeutics's accounts payable increased from $1.3M to $2.3M — a 83.9% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Better Therapeutics reported $2.3M in accounts payable as of September 2023. That compares with $1.3M in the prior-year period — up 83.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $2.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Better Therapeutics, and consider following BTTX for alerts when major investors trade the stock.